A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

@article{Bonnet2007AMC,
  title={A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.},
  author={S{\'e}bastien Bonnet and Stephen L. Archer and Joan Allalunis-Turner and Alois Haromy and Christian Beaulieu and Richard B. Thompson and Christopher T. Lee and Gary D. Lopaschuk and Lakshmi Puttagunta and Sandra N. Bonnet and Gwyneth Harry and Kyoko Hashimoto and Christopher J. Porter and Miguel A. Andrade and Bernard Th{\'e}baud and Evangelos D. Michelakis},
  journal={Cancer cell},
  year={2007},
  volume={11 1},
  pages={
          37-51
        }
}

Figures from this paper

Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
TLDR
Reverting the mitochondrial suppression with metabolic-modulating drugs, like PDK inhibitors or PKM2 activators holds promise in the rapidly expanding field of metabolic oncology.
Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer
TLDR
This work suggests that mitochondria-targeting metabolic modulators that increase pyruvate dehydrogenase activity, in addition to the recently described pro-apoptotic and anti-proliferative effects, suppress angiogenesis as well, normalizing the pseudo-hypoxic signals that lead to normoxic HIF1α activation in solid tumors.
The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
TLDR
Evidence suggests that MPC downregulation in tumor cells impacts many aspects of tumorigenesis, including cancer cell-intrinsic (proliferation, invasiveness, stemness, resistance to therapy) and -extrinsics (angiogenesis, anti-tumor immune activity) properties.
Molecular Pathways: Mitochondrial Reprogramming in Tumor Progression and Therapy
TLDR
New experimental evidence with PI3K antagonists in melanoma, glioblastoma, and prostate cancer shows that mitochondrial metabolism drives an elaborate process of tumor adaptation culminating with drug resistance and metastatic competency, and how best to target a resurgence of mitochondrial bioenergetics for cancer therapy is discussed.
Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.
TLDR
It is found that CD44, a cell surface marker for cancer stem cells, interacts with pyruvate kinase M2 (PKM2) and thereby enhances the glycolytic phenotype of cancer cells that are either deficient in p53 or exposed to hypoxia.
Emerging Anti-cancer Targets in Mitochondria
TLDR
Targeting of mitochondrial isocitrate dehydrogenase-2 by inhibitors or silencing elements would eliminate tumour cells surviving the harsh conditions of hypoxia and intermittent aglycemia as well as in progressive stages of malignancies with mutant IDH2 or IDH1.
miR‐128‐3p contributes to mitochondrial dysfunction and induces apoptosis in glioma cells via targeting pyruvate dehydrogenase kinase 1
TLDR
The experiments confirmed that the miR‐128‐3p/PDK1 axis played a pivotal role in cancer cell metabolism and growth, and suggest that therapeutic strategies to modulate the Warburg effect, such as targeting of PDK1, might act as a potential therapeutic target for glioma treatment.
Mitochondria : a target for anticancer therapy
TLDR
It is demonstrated that although these features contribute, the main cause of cell death induced by citrate is the activation of initiator caspases.
Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
TLDR
The mechanistic basis for DCA anti‐cancer activity was re‐evaluated in vitro using biochemical, cellular and proteomic approaches and the ability of DCA to target cell lines with defects in the electron transport chain and to synergize with existing chemotherapeutics supports further preclinical development.
...
...

References

SHOWING 1-10 OF 65 REFERENCES
HERG K+ channel, a regulator of tumor cell apoptosis and proliferation.
TLDR
It is shown that HERG conductance markedly promotes H2O2-induced apoptosis of various tumor cells, whereas HERG expression facilitates the tumor cell proliferation caused by tumor necrosis factor ligand (TNF-alpha) and coexpression of HERG and TNF receptor 1 on the cytoplasmic membrane is correlated with greater activities of nuclear transcription factor, nuclear factor-kappaB, in HERG-expressing tumor cells.
Activation of K+ channels: an essential pathway in programmed cell death.
TLDR
The targeting of K+ channels are discussed as a potential therapeutic tool in modulating apoptosis to maintain the balance between cell proliferation and cell death that is essential to the normal development and function of an organism.
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.
TLDR
It is shown that survivin, a member of the inhibitor of apoptosis gene family that is overexpressed in cancer, exists in a novel mitochondrial pool in tumor cells, where it prevents caspase activation and inhibits apoptosis.
Roles of K+ channels in regulating tumour cell proliferation and apoptosis
TLDR
A comprehensive overview of current status of research on K+ channels/currents in tumour cells is provided and focus is placed on the roles of K+ channel/ currents in regulating tumour cell proliferation and apoptosis.
The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression.
TLDR
Subcloned cell lines from SW620 cells establish that the probability for tumor development and progression is linked to stable differences in the intrinsic Deltapsim of colonic epithelial cells.
Akt Stimulates Aerobic Glycolysis in Cancer Cells
TLDR
It is suggested that activation of the Akt oncogene is sufficient to stimulate the switch to aerobic glycolysis characteristic of cancer cells and that Akt activity renders cancer cells dependent on aerobic glyCOlysis for continued growth and survival.
Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity.
TLDR
Interference with the binding of HXK II to mitochondria may be a practicable modality by which to potentiate the efficacy of conventional chemotherapeutic agents.
Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.
TLDR
Evidence is provided that the PDH/PDK pathway is repressed in 73% of non small cell lung carcinomas, which may be a key reason for HIF1alpha stabilization and "aerobic glycolysis" in patients harboring these tumors.
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
TLDR
Inhibition of the inappropriate expression of survivin that accompanies human and experimental PAH is a novel therapeutic strategy that acts by inducing vascular mitochondria-dependent apoptosis.
Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
TLDR
The results indicate that the Bcl-2 family of proteins bind to the VDAC in order to regulate the mitochondrial membrane potential and the release of cytochrome c during apoptosis.
...
...